Get started
Author

Dikla Atias

Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
2021 · Talia Golan, Grainne M. O’Kane, et al. · Gastroenterology · 155
Harnessing synthetic lethality to predict the response to cancer treatment
2018 · Joo Sang Lee, Avinash Das, et al. · Nature Communications · 131
PDF
Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice
2024 · Benjamin Assouline, Rachel Kahn, et al. · Nature Communications · 96
PDF
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA –Associated Pancreatic Cancer in the Clinical and Preclinical Setting
2023 · Chani Stossel, Maria Raitses-Gurevich, et al. · Cancer Discovery · 50
PDF
Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic Cancer
2019 · Aditi Jain, Lebaron C. Agostini, et al. · Cancer Research · 46
Thyroid hormones induce activation of rat hepatic stellate cells through increased expression of p75 neurotrophin receptor and direct activation of Rho
2010 · Isabel Zvibel, Dikla Atias, et al. · Laboratory Investigation · 37
Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease
2017 · Talia Golan, Chani Stossel, et al. · Oncotarget · 33
PDF
Recapitulating the clinical scenario of BRCA‐associated pancreatic cancer in pre‐clinical models
2018 · Talia Golan, Chani Stossel, et al. · International Journal of Cancer · 28
PDF
Ascites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine
2014 · T Golan, D Atias, et al. · British Journal of Cancer · 24
PDF
Patient-derived xenograft models of BRCA-associated pancreatic cancers
2021 · Talia Golan, Dikla Atias, et al. · Advanced Drug Delivery Reviews · 18
Exclusive destruction of mitotic spindles in human cancer cells
2017 · Leonid Visochek, Asher Castiel, et al. · Oncotarget · 18
PDF
Perinephric and Epididymal Fat Affect Hepatic Metabolism in Rats
2011 · Shani Ben‐Shlomo, Francine H. Einstein, et al. · Obesity · 12
A metabolic switch to the pentose-phosphate pathway induces radiation resistance in pancreatic cancer
2024 · Ariel Shimoni-Sebag, Ifat Abramovich, et al. · Radiotherapy and Oncology · 11
The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts
2019 · Leonid Visochek, Dikla Atias, et al. · Oncotarget · 5
PDF
RNA-seq and KRAS mutational status in ascitic pancreatic cancer cells: Novel results and distinct subsets.
2014 · Talia Golan, S. Gail Eckhardt, et al. · Journal of Clinical Oncology · 2
Abstract 2411: The pentose-phosphate pathway induces pancreatic cancer radioresistance, a preclinical study with clinical validation
2023 · Ariel Shimoni-Sebag, Ifat Abramovich, et al. · Cancer Research · 1
Abstract B045: Plasma cfDNA 5-hydroxymethylcytosine signatures associate with treatment response and molecular subtype in BRCA -mutant pancreatic cancer
2026 · Ceyda Coruh, Maria Raitses-Gurevich, et al. · Cancer Research
Abstract 1982: Genomic analyses of patient-derived xenografts reveal novel molecular subsets of PDAC and their association with clinical features.
2026 · Chani Stossel, Rotem Tal, et al. · Cancer Research
Abstract 6488: Dual targeting of PARP and RAS enhances antitumor activity in pancreatic cancer
2026 · Chani Stossel, Gali Altman, et al. · Cancer Research
Abstract 1273: Antitumor activity of PARPi and POLQi combination therapy in a BRCA-mutated PDAC model.
2026 · Chani Stossel, Dikla Atias, et al. · Cancer Research
Supplementary table 3 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
2025 · Chani Stossel, Maria Raitses-Gurevich, et al.
Supplementary figure 2 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
2025 · Chani Stossel, Maria Raitses-Gurevich, et al.
Supplementary figure 1 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
2025 · Chani Stossel, Maria Raitses-Gurevich, et al.
PDF
Supplementary table 2 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
2025 · Chani Stossel, Maria Raitses-Gurevich, et al.
Supplementary table 1 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
2025 · Chani Stossel, Maria Raitses-Gurevich, et al.
PDF
Works count: 90
Citation count: 667
H-index: 12
I10-index: 13
Year
Topic
Type